期刊文献+

自体肿瘤疫苗主动特异性免疫治疗对进展期肿瘤患者细胞免疫功能的影响 被引量:1

Effects of active immunotherapy with autologous tumor vaccine on cellular immune response in post-operative patients with advanced tumors
下载PDF
导出
摘要 目的 探讨自体肿瘤疫苗的作用机制。方法 15例进展期肿瘤患者术后,以自体肿瘤疫苗辅助主动免疫治疗。术后第4周开始免疫接种(共4次,每次间隔7~10 d);接种前3 d及4次接种后1周,采集外周血,分离单个核细胞,测定CD8+-IFN-γ+,CD8+-IL-10+细胞比例及CD4+-IFN-γ+、CD4+-IL-10+细胞比例;同时采集血清检测血清IFN-γ、IL-10水平。结果 自体疫苗治疗后:①血清IFN-γ水平升高,由(6.08±2.79)pg/ml升至(12.31±5.42)pg/ml;而IL-10水平由(26.14±14.01)pg/ml降至(7.21±3.01)pg/ml,差异有显著性(P<0.05)。②CD8+-IFN-γ+双阳性细胞比例由(2.61±1.01)%升至(5.96±2.17)%;CD4+-IFN-γ+双阳性细胞比例由(3.25±1.52)%升至(6.20±3.87)%,差异有显著性(P<0.05)。③患者耐受性良好,无溃疡等严重不良反应发生。④临床随访10~26个月,15例患者无肿瘤复发或转移。结论 ①自体肿瘤疫苗可激发患者特异性细胞介导的免疫反应。②自体疫苗可改善患者的抗瘤免疫反应;③自体肿瘤疫苗主动特异性免疫治疗,对于杀灭残留癌细胞、抗转移及复发有重要作用。 Objective To explore the mechanism of active immunotherapy with autologous tumor vaccine. Methods Altogether 15 patients with advanced tumors were enrolled in this study.Four weeks after operation,the patients received autologous tumor vaccine every 7-10 days for 4 times as an adjuvant active immunotherapy. Three days before the first vaccination and 7 days after the last one: peripheral blood mononuclear cells(PBMC) were isolated to assay the alteration of the ratios between CD8+ -IFN-r+ and CD8+ -IHO+ ,and between CD4* -IFN-r+ and CD4+ -IL-10+ cells.Meanwhile,serum IFN-r and IL-10 was determined.Results After active immunotherapy with autologous tumor vaccine: 1 The serum IFN-r increased from (6.08 ±?2.79)pg/ml to(12.31 ± 5. 42)pg/ml(P<0.05)and the serum IL-10 decreased from(26.14() 14.01)pg/ml to(7.21 ±3.01)pg/ml(P < 0.05).The proportion of CD4+-IFN-r+ cells elevated from(3.25 ± 1.52)% to(6.20±3.87)%(P<0.05) ;2 The proportion of CD8+-IFN-r+ cells elevated from(2.61 ± 1.01)% to(5.96± 2.17)%(P< 0.05) ; 3 The patients tolerated well without serious side-effects such as ulceration;4 Follow-up study showed that the disease-free periods of the 15 patients were 10 to 26 months (still alive) .Conclusion The autologous tumor vaccine can elicit specific cellular immune response and improve host's anti-tumor immune response.It may play an important role in improving life quality, survival and prevention of recurrence and metastasis.
出处 《中国肿瘤临床与康复》 2003年第2期100-103,共4页 Chinese Journal of Clinical Oncology and Rehabilitation
基金 陕西省科技攻关项目[2001 K10-G5(2)] 西安交通大学博士流动基金项目(011004)
关键词 自体肿瘤疫苗 主动特异性 免疫治疗 进展期 免疫接种 血清 IFN-Γ IL-10 肿瘤 Neoplasm vaccines Immunotherapy Neoplasm/therapy Cellular immune
  • 相关文献

参考文献15

  • 1Bend D, Henry C, Maguire JR. Autologous hapten-modified melanome vaccine as poatstagical adjuvant treatment after resection of nodal metastases[J]. Clin Oncol, 1997,15:2359-3370.
  • 2Galligioni E,Quaia M, Merlo A,et al.Adjuvant immotherapy treatment of renal carcinoma patients with autologous humor cells and Bacillus Calmette-Guerin.Five-year result of a prospective randomized study[J].Cancer,1999,72:25660-2566
  • 3Vermorken JB, Clasessena ME, Tinteren HV, et el. Active specific immunotherapy far stage Ⅱ and stage Ⅲ human colon cancer: a randomised trial[J]. Lancet, 1999,353:345-350.
  • 4Hsueh EC, Hsueh LN, Leland J, et al. Active specific inentmotherapy with polyvalent melanoma cell vaccine for patients with In-Transit melanoma metastases[J]. Cancer, 1999,85:2160-2169.
  • 5Schadendorf D,Paschen A, Sun Y. Autologous, allogeneie tumor cells or genetically engineered cells as cancer vaccine melanoma[J]. Immunol Lett,2000,74:67-74.
  • 6Chu Y, Hm D, Winter YH, et al. Examining the inanune response in sentinel lymph nodes of mice and men[J] .Eur Nucl Med, 1999,85:2160-2169.
  • 7Kaji D, Hengartner H. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic vinmes[J] .Curr Opin Immuml, 1996,8:471-477.
  • 8Clark WR, Walsh CM. Cell-mediated cytotoxieity in perforin-less mice[J] .lnt Res Immunol,1995,13:1-14.
  • 9Liu CC, Persechini F. Perforin and lymphocyte mediated cytolysis[J].Immunol Rev, 1995,146:145-175.
  • 10Van Parijis LJ and Abbas AK. Role of Fas-mediated cell death in the regulation of immune responses[J]. Curt Opin Inmmunol, 1996,8:355-361.

同被引文献15

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部